Why is URGN Up Today?
About UroGen Pharma Ltd. Ordinary Shares
UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagsh...
Overall Confidence: 60%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -1.6%
Market Comparison
🔔 Get URGN Alerts
We'll notify you when URGN's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
URGN has moved more than 3.0% up on 52 occasions in the past year.
Frequently Asked Questions
Why is URGN stock up today?
This stock is significantly outperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.
Is URGN stock a buy or sell right now?
Based on current analysis, URGN shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the URGN stock price target?
URGN is currently trading at $41.38. Based on today's momentum, the expected short-term range is $40.55 - $42.62. See long-term price prediction →
Will URGN stock continue rising?
Our analysis shows a 45% probability that URGN's move continues in the next 1-3 days. Key level to watch: $43.45 (resistance).
Is URGN stock oversold or overbought?
URGN's RSI (Relative Strength Index) is currently at 40.8. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for URGN stock?
URGN's 10-day momentum indicator is at -2.31. Strong bearish momentum - the stock is experiencing significant downward pressure. Watch for potential reversal signals.
Is URGN outperforming or underperforming the market?
URGN (+2.05%) is currently outperforming the market (+1.3% vs SPY). Today, the S&P 500 (SPY) is up 0.74%, and Nasdaq (QQQ) is up 1.02%.
What does MACD indicate for URGN?
URGN's MACD (-0.93) is currently below the signal line (-0.73), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 15.6) is weak.
Is URGN in an uptrend or downtrend?
Based on moving average analysis, URGN is in a bearish trend. The price ($41.38) is trading below both the 20-day SMA ($42.31) and 50-day SMA ($43.82). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis